Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
No of Months
12
12
Operating Income
172.00
156.00
Less :Inter divisional transfers
0.00
0.00
Less: Excise
0.00
0.00
Net Sales
172.00
156.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0.00
Raw Materials Consumed
100.00
81.00
Power & Fuel Cost
0.00
0.00
Employee Cost
15.00
9.00
Operating Expenses
5.00
5.00
General and Administration Expenses
-1.00
-1.00
Selling and Distribution Expenses
3.00
5.00
Cost of Software developments
0.00
0.00
Miscellaneous Expenses
23.00
20.00
Expenses Capitalised
0.00
0.00
Total Expenditure
146.00
130.00
Operating Profit (PBDIT) excl Other Income
25.00
25.00
Other Income
1.00
1.00
Operating Profit (PBDIT)
26.00
27.00
Interest
6.00
4.00
Profit before Depriciation and Tax
20.00
22.00
Depreciation
3.00
3.00
Profit Before Taxation & Exceptional Items
16.00
18.00
Exceptional Income / Expenses
0.00
0.00
Profit Before Tax
16.00
18.00
Provision for Tax
4.00
4.00
Profit After Tax
11.00
13.00
Extraordinary Items
0.00
0.00
Adj to Profit After Tax
0.00
0.00
Profit Balance B/F
41.00
30.00
Profit Available for appropriations
51.00
42.00
Appropriations
51.00
42.00
Equity Dividend (%)
50.00%
50.00%
Earnings Per Share
5.40
6.65
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 10.81% vs NA in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 1.85% vs NA in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 41.33% vs NA in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is -13.01% vs NA in Mar 2025
Compare Profit and Loss Results of QMS Medical
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
172.00
71.00
101.00
142.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
172.00
71.00
101.00
142.25%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
-1.00
-6.00
-600.00%
Raw Materials Consumed
100.00
17.00
83.00
488.24%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
15.00
13.00
2.00
15.38%
Operating Expenses
5.00
3.00
2.00
66.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
3.00
0.00
0.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
23.00
1.00
22.00
2,200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
146.00
46.00
100.00
217.39%
Operating Profit (PBDIT) excl Other Income
25.00
25.00
0.00
0.00%
Other Income
1.00
4.00
-3.00
-75.00%
Operating Profit (PBDIT)
26.00
29.00
-3.00
-10.34%
Interest
6.00
0.00
6.00
0%
Profit before Depriciation and Tax
20.00
29.00
-9.00
-31.03%
Depreciation
3.00
2.00
1.00
50.00%
Profit Before Taxation & Exceptional Items
16.00
27.00
-11.00
-40.74%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
16.00
27.00
-11.00
-40.74%
Provision for Tax
4.00
7.00
-3.00
-42.86%
Profit After Tax
11.00
20.00
-9.00
-45.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
41.00
73.00
-32.00
-43.84%
Profit Available for appropriations
51.00
93.00
-42.00
-45.16%
Appropriations
51.00
93.00
-42.00
-45.16%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
5.4
17.07
-11.67
-68.37%
Profit And Loss - Net Sales
Net Sales 172.88 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 10.81% vs NA in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.88 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.85% vs NA in Mar 2025
Profit And Loss - Interest
Interest 6.55 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 41.33% vs NA in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 11.92 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -13.01% vs NA in Mar 2025
Footer loading
